These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 15824967

  • 1. SAPK/JNK plays a role in transforming growth factor-beta-induced VEGF synthesis in osteoblasts.
    Kanno Y, Ishisaki A, Yoshida M, Tokuda H, Numata O, Kozawa O.
    Horm Metab Res; 2005 Mar; 37(3):140-5. PubMed ID: 15824967
    [Abstract] [Full Text] [Related]

  • 2. Involvement of SAPK/JNK in prostaglandin E(1)-induced VEGF synthesis in osteoblast-like cells.
    Kanno Y, Tokuda H, Nakajima K, Ishisaki A, Shibata T, Numata O, Kozawa O.
    Mol Cell Endocrinol; 2004 May 31; 220(1-2):89-95. PubMed ID: 15196703
    [Abstract] [Full Text] [Related]

  • 3. Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts.
    Tokuda H, Hirade K, Wang X, Oiso Y, Kozawa O.
    J Endocrinol; 2003 Apr 31; 177(1):101-7. PubMed ID: 12697041
    [Abstract] [Full Text] [Related]

  • 4. Involvement of stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) in prostaglandin F2alpha-induced heat shock protein 27 in osteoblasts.
    Tokuda H, Niwa M, Ishisaki A, Nakajima K, Ito H, Kato K, Kozawa O.
    Prostaglandins Leukot Essent Fatty Acids; 2004 May 31; 70(5):441-7. PubMed ID: 15062846
    [Abstract] [Full Text] [Related]

  • 5. Rho-kinase inhibitors decrease TGF-beta-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Kuno M, Takai S, Matsushima-Nishiwaki R, Minamitani C, Mizutani J, Otsuka T, Harada A, Adachi S, Kozawa O, Tokuda H.
    Biochem Pharmacol; 2009 Jan 15; 77(2):196-203. PubMed ID: 18996357
    [Abstract] [Full Text] [Related]

  • 6. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Takai S, Tokuda H, Hanai Y, Harada A, Yasuda E, Matsushima-Nishiwaki R, Kato H, Ogura S, Ohta T, Kozawa O.
    J Bone Miner Res; 2007 Mar 15; 22(3):337-46. PubMed ID: 17181399
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
    Tokuda H, Takai S, Matsushima-Nishiwaki R, Akamatsu S, Hanai Y, Hosoi T, Harada A, Ohta T, Kozawa O.
    J Cell Biochem; 2007 Apr 01; 100(5):1146-53. PubMed ID: 17031857
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Wnt3a upregulates transforming growth factor-β-stimulated VEGF synthesis in osteoblasts.
    Natsume H, Tokuda H, Matsushima-Nishiwaki R, Kato K, Yamakawa K, Otsuka T, Kozawa O.
    Cell Biochem Funct; 2011 Jul 01; 29(5):371-7. PubMed ID: 21491471
    [Abstract] [Full Text] [Related]

  • 12. Involvement of p38 MAP kinase in TGF-beta-stimulated VEGF synthesis in aortic smooth muscle cells.
    Yamamoto T, Kozawa O, Tanabe K, Akamatsu S, Matsuno H, Dohi S, Uematsu T.
    J Cell Biochem; 2001 Jul 01; 82(4):591-8. PubMed ID: 11500937
    [Abstract] [Full Text] [Related]

  • 13. Involvement of AMP-activated protein kinase in TGF-β-stimulated VEGF synthesis in osteoblasts.
    Mizutani J, Tokuda H, Matsushima-Nishiwaki R, Kato K, Kondo A, Natsume H, Kozawa O, Otsuka T.
    Int J Mol Med; 2012 Apr 01; 29(4):550-6. PubMed ID: 22294055
    [Abstract] [Full Text] [Related]

  • 14. Resveratrol Inhibits the Epidermal Growth Factor-Induced Migration of Osteoblasts: the Suppression of SAPK/JNK and Akt.
    Kawabata T, Tokuda H, Fujita K, Kainuma S, Sakai G, Matsushima-Nishiwaki R, Kozawa O, Otsuka T.
    Cell Physiol Biochem; 2017 Apr 01; 43(3):1025-1036. PubMed ID: 28968596
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oncostatin M reduces the synthesis of macrophage-colony stimulating factor stimulated by TGF-β via suppression of p44/p42 MAP kinase and JNK in osteoblasts.
    Doi T, Hioki T, Tachi J, Ueda K, Matsushima-Nishiwaki R, Iida H, Ogura S, Kozawa O, Tokuda H.
    Biomed Res; 2022 Apr 01; 43(2):41-51. PubMed ID: 35431291
    [Abstract] [Full Text] [Related]

  • 18. Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts.
    Tokuda H, Takai S, Hanai Y, Harada A, Matsushima-Nishiwaki R, Kato H, Ogura S, Kozawa O.
    J Bone Miner Metab; 2008 Apr 01; 26(4):335-41. PubMed ID: 18600399
    [Abstract] [Full Text] [Related]

  • 19. Involvement of Rho-kinase in prostaglandin E(1)-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblast-like MC3T3-E1 cells.
    Adachi S, Tokuda H, Matsushima-Nishiwaki R, Kato K, Natsume H, Minamitani C, Mizutani J, Otsuka T, Kozawa O.
    Prostaglandins Other Lipid Mediat; 2009 Nov 01; 90(1-2):1-6. PubMed ID: 19524699
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus but not cyclosporine A enhances FGF-2-induced VEGF release in osteoblasts.
    Yamauchi J, Takai S, Matsushima-Nishiwaki R, Adachi S, Minamitani C, Natsume H, Mizutani J, Otsuka T, Takeda J, Harada A, Kozawa O, Tokuda H.
    Int J Mol Med; 2009 Feb 01; 23(2):267-72. PubMed ID: 19148552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.